logo of the vendor
Pharma Intelligence UK Ltd logo

Enrollment Strategies For Vaccine Research In A Post-COVID Era

thumbnail of content

In a post-COVID era, enrolling patients in vaccine studies has proven to be more challenging, accounting for vaccine misinformation and hesitancy, along with patient fatigue.


Join us on September 15th at 10am ET as experts discuss the current landscape of patient enrollment in vaccine clinical trials as well as:

  • How to reach patients that may be burnt-out on vaccine information.
  • How to overcome vaccine misinformation and safety concerns.
  • Strategies for site selection to maximise diversity.
  • How to support patient groups that may be research naïve.

Register for the Webinar

    Opt In?

    Please complete all required fields to access the content!

    Explore similar content

    IQVIA
    Pharma Intelligence UK Ltd

    Future-Ready Pharmacovigilance: Integrating AI With FDA's EDSTP Guidelines

    Join IQVIA’s esteemed panel of experts for an in-depth discussion on how AI can meet and exceed these new expectations. This webinar delves into the intersection of regulatory frameworks and technological innovation, offering insights into the future of PV and how organizations can navigate this transformative field. Key takeaways include:
    Webinar Clinical Studies Pharmaceutical Research and Development
    ThermoFisher
    Pharma Intelligence UK Ltd

    Accelerating Biologics Development With Strategies For Success

    The biologics market is growing rapidly, unlocking exciting opportunities but also presenting significant challenges. Developers are undergoing pressure to accelerate the delivery of innovative therapies while addressing complex regulatory demands, navigating demanding clinical trial phases, efficiently scaling production, and maintaining quality. In this webinar, industry experts will share practical strategies and real-world examples to help you navigate these challenges. Key takeaways:
    Webinar Clinical Studies Pharmaceutical Research and Development
    IQVIA Technologies
    Pharma Intelligence UK Ltd

    A New Era of Participant Payment Services

    Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:
    Article Clinical Studies Pharmaceutical Research and Development